BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6139689)

  • 1. Antiphospholipid antibodies in acute Guillain-Barré syndrome.
    Harris EN; Englert H; Derve G; Hughes GR; Gharavi A
    Lancet; 1983 Dec; 2(8363):1361-2. PubMed ID: 6139689
    [No Abstract]   [Full Text] [Related]  

  • 2. [Guillain-Barre syndrome and antibodies to ganglioside GM1. Case report].
    Trisković I; Dimitrijević Lj; Rakocević-Stojanović V; Trikić R; Apostolski S
    Srp Arh Celok Lek; 1996; 124(7-8):210-3. PubMed ID: 9102850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New aspects of the pathogenesis and therapy of Guillain-Barré syndrome and chronic polyneuritis].
    Hartung HP; Heininger K; Toyka KV
    Nervenarzt; 1990 Apr; 61(4):197-207. PubMed ID: 2191228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
    Ho TW; Mishu B; Li CY; Gao CY; Cornblath DR; Griffin JW; Asbury AK; Blaser MJ; McKhann GM
    Brain; 1995 Jun; 118 ( Pt 3)():597-605. PubMed ID: 7600081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axonal degeneration in the Guillain-Barré syndrome and anti-GM1 ganglioside antibodies.
    Yuki N; Sato S; Inuzuka T; Miyatake T; Yoshino H
    Muscle Nerve; 1992 Jan; 15(1):116. PubMed ID: 1732757
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guillain-Barré syndrome associated with anti-GQ1b antibody--nosological relationship between Fisher's syndrome and Guillain-Barré syndrome].
    Jibiki T; Shimizu N; Terashima I; Yuki N
    Rinsho Shinkeigaku; 1994 Apr; 34(4):381-4. PubMed ID: 8026135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma exchange in patients with Guillain-Barré syndrome: clinical improvement in patients with serum IgG antibodies to peripheral nerve tissue.
    Nyland H; Vedeler CA; Matre R; Halvorsen K; Fagius J; Osterman PO; Janzen RW; Skre H
    Int J Artif Organs; 1984 May; 7(3):133-6. PubMed ID: 6735503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of IgA anti-GM1 antibody with antecedent diarrhea in patients with Guillain-Barré syndrome].
    Koga M; Yuki N; Hirata K
    Rinsho Shinkeigaku; 1997 Sep; 37(9):848-50. PubMed ID: 9431003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An acute axonal form of Guillain-Barré syndrome with antibodies against gangliosides GM1 and GD1b--a case report].
    Yuki N; Yoshino H; Sato S; Ohno T; Miyatake T
    Rinsho Shinkeigaku; 1990 Sep; 30(9):989-93. PubMed ID: 2265511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GM 1 antibodies in Guillain-Barré syndrome: isotypes, course and clinical outcome.
    Seiser A; Pötzl G; Safoschnik G; Pichler S; Bernheimer H; Schwerer B
    Wien Klin Wochenschr; 1994; 106(6):159-63. PubMed ID: 8197746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [No association between IgG anti-GTla antibody and bulbar palsy in Guillain-Barré and Fisher's syndromes].
    Koga M; Yuki N; Hirata K
    Rinsho Shinkeigaku; 1997 Nov; 37(11):1024-6. PubMed ID: 9503976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology of the motor-sensory axonal Guillain-Barré syndrome.
    Griffin JW; Li CY; Ho TW; Tian M; Gao CY; Xue P; Mishu B; Cornblath DR; Macko C; McKhann GM; Asbury AK
    Ann Neurol; 1996 Jan; 39(1):17-28. PubMed ID: 8572662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour necrosis factor-alpha and other cytokines in Guillain-Barré syndrome.
    Exley AR; Smith N; Winer JB
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1118-20. PubMed ID: 8089682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.
    Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP
    Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome.
    Jacobs BC; van Doorn PA; Groeneveld JH; Tio-Gillen AP; van der Meché FG
    J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):641-3. PubMed ID: 9219756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-GM1 antibodies in patients with Guillain-Barré syndrome.
    van den Berg LH; Marrink J; de Jager AE; de Jong HJ; van Imhoff GW; Latov N; Sadiq SA
    J Neurol Neurosurg Psychiatry; 1992 Jan; 55(1):8-11. PubMed ID: 1548508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal restriction of complement-fixing antineural antibodies in the Guillain-Barré syndrome.
    Ryberg B
    Ann N Y Acad Sci; 1988; 540():384-6. PubMed ID: 3207264
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fisher syndrome and anti-GQ1b antibody].
    Kusunoki S; Chiba A
    Nihon Rinsho; 1994 Nov; 52(11):2959-64. PubMed ID: 7996694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiganglioside antibodies in the CSF of patients with motor neuron diseases and Guillain-Barré syndrome.
    Iñiguez C; Jiménez-Escrig A; Gobernado JM; Nocito M; Gonzalez-Porque P
    J Neurol Neurosurg Psychiatry; 1995 Apr; 58(4):519-20. PubMed ID: 7738582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.